Visual-spatial learning impairments are associated with hippocampal PSD-95 protein dysregulation in a mouse model of fragile X syndrome

NeuroReport

Volumn 25, Issue 4, 2014, Pages 255-261

  Gandhi, Réno M ^a   Kogan, Cary S ^a   Messier, Claude ^a   Macleod, Lindsey S ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Fragile X syndrome; Hebb Williams mazes; hippocampus; visual spatial learning and memory; western blot

Indexed keywords

BETA TUBULIN; FRAGILE X MENTAL RETARDATION PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95;

ACCLIMATIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FLUORESCENCE; FRAGILE X SYNDROME; GENOTYPE; HIPPOCAMPUS; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPATIAL LEARNING; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CA1 REGION, HIPPOCAMPAL; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE EXPRESSION REGULATION; GUANYLATE KINASE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MAZE LEARNING; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; PRACTICE (PSYCHOLOGY); TASK PERFORMANCE AND ANALYSIS; TUBULIN;

EID: 84896730219     PISSN: 09594965     EISSN: 1473558X     Source Type: Journal    
DOI: 10.1097/WNR.0000000000000087     Document Type: Article

References (26)

1. O'Donnell WT, Warren ST. A decade of molecular studies of fragile X syndrome. Annu Rev Neurosci 2002; 25:315-338.
2. Kogan CS, Boutet I, Cornish K, Graham GE, Berry-Kravis E, Drouin A, et al. A comparative neuropsychological test battery differentiates cognitive signatures of Fragile X and Down syndrome. J Intellect Disabil Res 2009; 53:125-142.
3. MacLeod LS, Kogan CS, Collin CA, Berry-Kravis E, Messier C, Gandhi R. A comparative study of the performance of individuals with fragile X syndrome and Fmr1 knockout mice on Hebb-Williams mazes. Genes Brain Behav 2010; 9:53-64.
4. Bakker CE, Verheij C, Willemsen R, van der Helm R, Oerlemans F, Vermey M, et al. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 1994; 78:23-33.
5. Kooy RF. Of mice and the fragile X syndrome. Tr e n d s G e n e t 2003; 19:148-154.
6. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet 1993; 4:147-153.
7. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, et al. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet 1993; 3:36-43.
8. Baker KB, Wray SP, Ritter R, Mason S, Lanthorn TH, Savelieva KV. Male and female Fmr1 knockout mice on C57 albino background exhibit spatial learning and memory impairments. Genes Brain Behav 2010; 9:562-574.
9. Rogers JL, Kesner RP. Lesions of the dorsal hippocampus or parietal cortex differentially affect spatial information processing. Behav Neurosci 2006; 120:852-860.
10. Winocur G, Moscovitch M. Hippocampal and prefrontal cortex contributions to learning and memory: analysis of lesion and aging effects on maze learning in rats. Behav Neurosci 1990; 104:544-551.
11. Malenka RC, Bear MF. LTP and LTD: an embarrassment of riches. Neuron 2004; 44:5-21.
12. Schnell E, Sizemore M, Karimzadegan S, Chen L, Bredt DS, Nicoll RA. Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci USA 2002; 99:13902-13907.
13. Keith D, El-Husseini A. Excitation control: balancing PSD-95 function at the synapse. Front Mol Neurosci 2008; 1:4.
14. El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS. PSD-95 involvement in maturation of excitatory synapses. Science 2000; 290:1364-1368.
15. Steiner P, Higley MJ, Xu W, Czervionke BL, Malenka RC, Sabatini BL. Destabilization of the postsynaptic density by PSD-95 serine 73 phosphorylation inhibits spine growth and synaptic plasticity. Neuron 2008; 60:788-802.
16. Levenga J, de Vrij FM, Buijsen RA, Li T, Nieuwenhuizen IM, Pop A, et al. Subregion-specific dendritic spine abnormalities in the hippocampus of Fmr1 KO mice. Neurobiol Learn Mem 2011; 95:467-472.
17. Bagni C, Greenough WT. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci 2005; 6:376-387.
18. Muddashetty RS, Kelic S, Gross C, Xu M, Bassell GJ. Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 2007; 27:5338-5348.
19. Todd PK, Mack KJ, Malter JS. The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci USA 2003; 100:14374-14378.
20. Zhu ZW, Xu Q, Zhao ZY, Gu WZ, Wu DW. Spatiotemporal expression of PSD-95 in Fmr1 knockout mice brain. Neuropathology 2011; 31:223-229.
21. Rabinovitch MS, Rosvold HE. A closed-field intelligence test for rats. Can J Psychol 1951; 5:122-128.
22. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press; 2001.
23. Gylys KH, Fein JA, Yang F, Wiley DJ, Miller CA, Cole GM. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am J Pathol 2004; 165:1809-1817.
24. Toro C, Deakin JF. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 2005; 80:323-330.
25. Liu ZH, Chuang DM, Smith CB. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome. Int J Psychopharmacol 2011; 14:618-630.
26. Bhakar AL, Dolen G, Bear MF. The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 2012; 35:417-443. Council of Canada